Clinical Benefit
| Moderate |
Le service médical rendu par cette spécialité est modéré dans l’hypertrophie bénigne de la prostate non compliquée.
|
Clinical Added Value
| no clinical added value |
OMEXEL LP 0,4mg (gel matriciel) n’apporte pas d’amélioration du service.
|
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
ZdvUQm2psa9ym39U